OTCMKTS:QNNTF

Quantum Genomics Société Anonyme (QNNTF) Stock Price, News & Analysis

$0.10
0.00 (0.00%)
(As of 04/26/2024 ET)
Today's Range
$0.10
$0.10
50-Day Range
$0.10
$0.10
52-Week Range
$0.10
$0.10
Volume
N/A
Average Volume
1,000 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
QNNTF stock logo

About Quantum Genomics Société Anonyme Stock (OTCMKTS:QNNTF)

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.

QNNTF Stock Price History

QNNTF Stock News Headlines

Quantum Genomics Share From reverse split ALQGC
Quantum Genomics SA (ALQGC)
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Quantum Genomics Société Anonyme (ALQGC.PA)
ALQGC.PA: First Half Results
ALQGC: FRESH Results in November
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
See More Headlines
Receive QNNTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Genomics Société Anonyme and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
OTCMKTS:QNNTF
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.22
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Jean-Philippe Milon Ph.D. (Age 64)
    CEO, MD & Chairman
    Comp: $443k
  • Dr. Sarah Merlen-Boulenger
    Head of Regulatory Affairs

QNNTF Stock Analysis - Frequently Asked Questions

How have QNNTF shares performed in 2024?

Quantum Genomics Société Anonyme's stock was trading at $0.1010 at the start of the year. Since then, QNNTF stock has decreased by 1.0% and is now trading at $0.10.
View the best growth stocks for 2024 here
.

How do I buy shares of Quantum Genomics Société Anonyme?

Shares of QNNTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:QNNTF) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners